Microbes as triggers and boosters of Type 1 Diabetes - Mediation by molecular mimicry.
暂无分享,去创建一个
[1] M. Kriegel,et al. Evolving concepts of host-pathobiont interactions in autoimmunity. , 2022, Current opinion in immunology.
[2] L. Putignani,et al. Pathophysiology of Type 1 Diabetes and Gut Microbiota Role , 2022, International journal of molecular sciences.
[3] S. Berger,et al. SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry , 2022, Nature.
[4] J. Gaglia,et al. Adult-onset autoimmune diabetes , 2022, Nature Reviews Disease Primers.
[5] Nicholas D. Youngblut,et al. Vertebrate host phylogeny influences gut archaeal diversity , 2021, Nature Microbiology.
[6] J. Dunne,et al. Adult-Onset Type 1 Diabetes: Current Understanding and Challenges , 2021, Diabetes Care.
[7] Tanja M Lunić,et al. Mining the capacity of human-associated microorganisms to trigger rheumatoid arthritis—A systematic immunoinformatics analysis of T cell epitopes , 2021, PloS one.
[8] B. Guigas,et al. Endoplasmic Reticulum-Mitochondria Crosstalk and Beta-Cell Destruction in Type 1 Diabetes , 2021, Frontiers in Immunology.
[9] E. James,et al. Non-Genetically Encoded Epitopes Are Relevant Targets in Autoimmune Diabetes , 2021, Biomedicines.
[10] B. Roep,et al. Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?) , 2020, Nature Reviews Endocrinology.
[11] Michael R Hamblin,et al. Autoantigen-specific immune tolerance in pathological and physiological cell death: Nanotechnology comes into view. , 2020, International immunopharmacology.
[12] L. Wen,et al. Gut microbial metabolites alter IgA immunity in type 1 diabetes. , 2020, JCI insight.
[13] Mark S. Anderson,et al. Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes , 2019, Diabetes Care.
[14] J. Ilonen,et al. The heterogeneous pathogenesis of type 1 diabetes mellitus , 2019, Nature Reviews Endocrinology.
[15] Alexandra J. Roth-Schulze,et al. Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study , 2019, Pediatric diabetes.
[16] William A. Walters,et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 , 2019, Nature Biotechnology.
[17] C. Yau,et al. Association of HLA-dependent islet autoimmunity with systemic antibody responses to intestinal commensal bacteria in children , 2019, Science Immunology.
[18] Chengfei Yan,et al. MDockPeP: An ab‐initio protein–peptide docking server , 2018, J. Comput. Chem..
[19] C. Huttenhower,et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study , 2018, Nature.
[20] D. Serreze,et al. HLA-B*39:06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression , 2018, The Journal of Immunology.
[21] M. Redondo,et al. Genetics of type 1 diabetes , 2018, Pediatric diabetes.
[22] Chengfei Yan,et al. Fully Blind Docking at the Atomic Level for Protein-Peptide Complex Structure Prediction. , 2016, Structure.
[23] Bjoern Peters,et al. TepiTool: A Pipeline for Computational Prediction of T Cell Epitope Candidates , 2016, Current protocols in immunology.
[24] M. Cunningham. Rheumatic Fever, Autoimmunity, and Molecular Mimicry: The Streptococcal Connection , 2014, International reviews of immunology.
[25] K. Coppieters,et al. Viral infections and molecular mimicry in type 1 diabetes , 2012, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[26] D. Finegold,et al. Phase I (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients , 2011, Diabetes Care.
[27] W. Langridge,et al. Autoantigen based vaccines for type 1 diabetes. , 2011, Discovery medicine.
[28] K. Vehik,et al. The changing epidemiology of type 1 diabetes: why is it going through the roof? , 2011, Diabetes/metabolism research and reviews.
[29] J. Isaacs,et al. Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis , 2010, Annals of the Rheumatic Diseases.
[30] D. Raoult,et al. Gene Repertoire of Amoeba-Associated Giant Viruses , 2010, Intervirology.
[31] Alessandro Sette,et al. The Immune Epitope Database 2.0 , 2009, Nucleic Acids Res..
[32] C. Polychronakos,et al. The molecular genetics of type 1 diabetes: new genes and emerging mechanisms. , 2008, Trends in molecular medicine.
[33] J. Harley,et al. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus , 2006, Autoimmunity.
[34] L. Guilherme,et al. Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease , 2006, Autoimmunity.
[35] M. Raška,et al. Heat shock proteins in autoimmune diseases. , 2005, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.
[36] J. Laman,et al. The Guillain-Barré syndrome: a true case of molecular mimicry. , 2004, Trends in immunology.
[37] Haruki Nakamura,et al. Announcing the worldwide Protein Data Bank , 2003, Nature Structural Biology.
[38] N. Rose,et al. Type 1 diabetes: virus infection or autoimmune disease? , 2002, Nature Immunology.
[39] J J Couper,et al. Environmental triggers of type 1 diabetes , 2001, Journal of paediatrics and child health.
[40] M. Jäättelä,et al. Heat shock proteins as cellular lifeguards. , 1999, Annals of medicine.
[41] G. Friman,et al. Coxsackie B virus IgM in children at onset of Type 1 (insulin-dependent) diabetes mellitus: evidence for IgM induction by a recent or current infection , 1992, Diabetologia.
[42] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.